Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study
The current crisis of the COVID-19 pandemic around the world has been devastating as many lives have been lost to the novel SARS CoV-2 virus. Thus, there is an urgent need for the right therapeutic drug to curb the disease. However, there is time constraint in drug development, hence the need for dr...
Gardado en:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2021-09-01
|
| Series: | Scientific African |
| Assuntos: | |
| Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S2468227621001496 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|